1648P Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI)Joshua M. Lang, Christos E. Kyriakopoulos, Susan F. Slovin et al.|Annals of Oncology|2024Cited by 7